Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03256539 · ClinicalTrials.gov registry record · NA
Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease
A NA study, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03256539 is a NA study that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 15 participants.
The verdict
NCT03256539, a NA study, was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study aimed to pilot test a non-pharmacological (behavioral) treatment program targeting improved cognition through improving 24-h sleep-wake cycle in people with mild cognitive impairment (MCI) or mild Alzheimer's disease. A treatment program incorporating bright light therapy and a modified cognitive behavioral therapy for insomnia will be developed to address 24-hour patterns of sleep. We will then pilot test its feasibility and explore its preliminary effects on improving sleep/napping and cognition in patients with MCI or mild Alzheimer's disease.
Interventions
- BEHAVIORAL Sleep intervention
- BEHAVIORAL Placebo intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2021-08-12 |
| Est. Completion | 2024-01-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03256539
The ClinicalTrials.gov registry entry for NCT03256539 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep intervention is the first listed.
NCT03256539 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03256539 about?
NCT03256539 is a clinical study titled "Napping, Sleep, Cognitive Decline and Risk of Alzheimer's Disease". This study aimed to pilot test a non-pharmacological (behavioral) treatment program targeting improved cognition through improving 24-h sleep-wake cycle in people with mild cognitive impairment (MCI) or mild Alzheimer's disease. A treatment program incorporating bright light therapy and a modified c...
What is the current status of trial NCT03256539?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2021-08-12. Estimated completion is 2024-01-31.
What interventions are being tested in trial NCT03256539?
The interventions under investigation include: Sleep intervention (BEHAVIORAL), Placebo intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03256539?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.